Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study reports safety, tolerability, and pharmacokinetics of a single oral dose of SKI-O-703 in healthy volunteers, with rheumatoid arthritis noted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SKI-O-703 (SKI-O-703)

Snippet

Sponsor: Oscotec Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED